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Background: This study investigated the association between changes in anthropometric indices and fasting insulin levels among 
healthy adolescents and whether the association differed by baseline obesity status.
Methods: This analysis was based on data collected for the JS High School study; 884 healthy adolescents aged 15 to 16 years fol-
lowed up for 24 to 30 months were included. Changes in anthropometric indices and fasting insulin levels were computed as the 
difference between baseline and follow-up values. Multivariate linear regression models were used to determine the association 
between changes in anthropometric indices and fasting insulin levels. Based on body mass index (BMI)-for-age and waist cir-
cumference (WC)-for-age percentiles, participants were classified as normal weight (<85th percentile), overweight (85th percen-
tile to <95th percentile), or obese (≥95th percentile).
Results: Changes in BMI, WC, waist-hip ratio, and waist-height ratio were significantly associated with changes in fasting insulin 
levels in both sexes (P<0.05). In analyses stratified by baseline obesity status, the association between change in BMI and change 
in fasting insulin was significantly stronger in overweight (males: standardized β=1.136; females: standardized β=1.262) and 
obese (males: standardized β=1.817; females: standardized β=2.290) participants than in those with normal weight (males: stan-
dardized β=0.957; females: standardized β=0.976) at baseline. Results were similar for changes in WC.
Conclusion: Changes in anthropometric indices were positively associated with fasting insulin level increases. Moreover, those 
who were overweight or obese at baseline had a higher absolute increase in fasting insulin levels per one standard deviation unit 
increase in anthropometric indices than adolescents with normal weight.
Keywords: Adolescent; Insulin; Obesity
Corresponding author: Hyeon Chang Kim  https://orcid.org/0000-0001-7867-1240 
Department of Preventive Medicine, Yonsei University College of Medicine, 50-1 Yonsei-
ro, Seodaemun-gu, Seoul 03722, Korea  
E-mail: hckim@yuhs.ac
Received: Feb. 19, 2018; Accepted: Nov. 8, 2018
INTRODUCTION
According to the World Health Organization, childhood over-
weight and obesity are among the most serious health issues 
that cause secondary health problems and lead to obesity in 
adulthood [1]. In the United States, the prevalence of obesity 
for children and adolescents was 16.9% in 2009 to 2010 [2]. In 
Korea, the prevalence of childhood and adolescent obesity has 
increased from 5.8% in 1997 to 9.7% in 2005, with the increase 
more pronounced in boys, particularly those aged 13 to 18 
years [3]. In particular, Korean adolescents have less physical 
activities and increased sedentary behavior because of their 
daily schoolwork, making them obese [4,5].
The association between obesity and insulin resistance has 
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been reported in observational studies [6-10]. Adolescent obe-
sity is associated with an increased risk of developing insulin 
resistance in adulthood [9,10]. Recent studies have demon-
strated that high levels of glucose homeostasis variables, such 
as glucose, insulin, and homeostasis model assessment of insu-
lin resistance (HOMA-IR), in childhood not only persist into 
adulthood but also predict pre-diabetes and type 2 diabetes 
mellitus and are related to cardiometabolic risk factors in 
adults [7,8]. There is also evidence that insulin resistance are 
not only the result of obesity, but also the possibility of contrib-
uting to the onset of obesity [11]. Despite extensive studies on 
insulin resistance and obesity, the association between changes 
in anthropometric indices during adolescents and changes in 
levels of glucose homeostasis variables remains unclear.
Therefore, we investigated the association between changes 
in anthropometric indices and change in fasting insulin levels 
over 2.4 years and further investigated whether the association 
differs according to obesity status at baseline.
METHODS
Study population
Our study was based on data collected for the JS High School 
study, which is a prospective cohort study of a Korean adoles-
cent population. The target population of the JS High School 
study was first graders at a high school located in a rural area 
of South Korea. Baseline examinations were conducted on 
1,071 participants in 2007, 2010, 2011, and 2012. Participants 
enrolled from 2007 through 2011 were re-examined after 30 
months of follow-up, and those enrolled in 2012 were re-ex-
amined after 24 months of follow-up. We based our study on 
the 884 participants who participated in both the baseline in-
vestigations at first grade and the re-examination at third 
grade. The details of the study design and procedures have 
been previously described [12]. All participants had no previ-
ous diagnosis of diabetes mellitus or hypertension. Informed 
consent was obtained from each student as well as from his/
her parent or guardian after full explanation of the purpose 
and process of the study. The study protocol and consent pro-
cedure were approved by the Institutional Review Board of 
Severance Hospital at Yonsei University College of Medicine 
(approval No. 4-20100169).
Measurements
Health-related lifestyle factors and disease history were evalu-
ated using self-administered questionnaires. Smokers were de-
fined as participants who smoked at least 100 cigarettes in their 
lifetime. Drinkers were defined as participants who consumed 
alcoholic beverages at least once a month over the last year. 
Regular exercise was defined as engaging in physical activity 
for at least 30 minutes once a week at moderate intensity, either 
indoor or outdoor. Height was measured to the nearest 0.1 cm 
using a stadiometer, while body weight was measured to the 
nearest 0.1 kg on a digital scale (Seca 763; SECA, Hamburg, 
Germany), with the subject wearing his/her school uniform. 
Body mass index (BMI) was calculated as weight in kilograms 
divided by the square of height in meters (kg/m2). Waist cir-
cumference (WC) was measured between the lower borders of 
the rib cage and the iliac crest with a measuring tape. Hip cir-
cumference was measured at the level of widest circumference 
over the greater trochanters. Waist-hip ratio (WHR) was cal-
culated as WC divided by hip circumference. Waist-height ra-
tio (WHtR) was calculated as WC divided by height.
Resting blood pressure was measured twice at 5-minute in-
tervals using an automatic sphygmomanometer (Dinamap 
1846 SX/P; GE, Chicago, IL, USA) with the participant in the 
sitting position. If the two readings differed by more than 10 
mm Hg, additional measurements were obtained and the last 
two readings were averaged. Fasting blood samples were drawn 
after at least an 8-hour fasting. Serum concentrations of total 
cholesterol, high density lipoprotein cholesterol (HDL-C), and 
triglycerides were measured via enzymatic methods using an 
autoanalyzer (ADVIA 1800; Siemens Healthcare Diagnostics 
Inc., Deerfield, IL, USA). Fasting glucose level was measured 
via a glucose hexokinase method. The insulin level was mea-
sured via a radioimmunometric method. The HOMA-IR was 
calculated as the product of the fasting plasma insulin level 
(µIU/L) and the fasting plasma glucose level (mg/dL) divided 
by 405.
Statistical analysis
Data are presented either as mean±standard deviation or 
number with percent. Differences between baseline and fol-
low-up were analyzed using a paired t-test. Correlations be-
tween variables were evaluated using Spearman’s correlation 
coefficient. Multivariate linear regression models were used to 
examine the association between anthropometric indices and 
fasting insulin levels, adjusting for potential confounding vari-
ables, including age, smoking status, alcohol intake, and physi-
cal activity. To examine whether the association was dependent 
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on baseline obesity status, we stratified the analyses according 
to the following baseline categories of BMI and WC. Sex-spe-
cific BMI-for-age and WC-for-age percentiles were calculated 
following the 2007 Korean National Growth Charts [13]. 
Based on BMI-for-age percentiles, participants were classified 
as normal weight (<85th percentile), overweight (85th percen-
Table 1. Clinical characteristics at baseline and follow-up examinations
Variable Baseline Follow-up Change P value
Male (n=458)
   Age, yr 15.9±0.4 18.3±0.3 2.4±0.2 <0.001
   Height, cm 171.4±5.2 172.9±5.1 1.5±1.6 <0.001
   Weight, kg 64.8±10.1 68.1±10.3 3.2±4.6 <0.001
   BMI, kg/m2 22.0±3.1 22.7±3.0 0.7±1.5 <0.001
   WC, cm 73.4±7.9 75.7±8.1 2.3±5.0 <0.001
   Hip circumference, cm 94.2±6.3 96.0±6.7 1.8±5.2 <0.001
   WHR, % 77.8±5.1 78.8±5.9 1.0±6.1 0.001
   WHtR, % 42.8±4.6 43.8±4.6 0.9±3.0 <0.001
   Systolic blood pressure, mm Hg 115.1±12.7 123.7±11.7 8.6±12.9 <0.001
   Diastolic blood pressure, mm Hg 61.5±7.9 68.7±7.8 7.2±9.2 <0.001
   Total cholesterol, mg/dL 149.0±25.4 158.8±28.8 10.1±18.2 <0.001
   Triglycerides, mg/dL 76 (59–97) 68 (52–89) −6.5±34.6 <0.001
   HDL-C, mg/dL 44.6±10.3 52.1±10.4 7.6±8.8 <0.001
   Fasting glucose, mg/dL 88.3±7.1 83.2±7.5 −5.1±7.3 <0.001
   Insulin, µIU/L 8.5±2.8 9.8±5.0 1.2±4.7 <0.001
   HOMA-IR 1.9±0.7 2.0±1.3 0.2±1.2 0.007
Female (n=426)
   Age, yr 15.9±0.4 18.3±0.3 2.4±0.2 <0.001
   Height, cm 159.9±5.0 160.5±5.1 0.6±0.8 <0.001
   Weight, kg 54.2±7.4 56.0±8.2 1.8±3.8 <0.001
   BMI, kg/m2 21.2±2.6 21.7±2.9 0.6±1.5 <0.001
   WC, cm 68.6±6.7 69.7±8.3 1.1±7.4 0.002
   Hip circumference, cm 93.2±5.2 94.0±5.8 0.8±3.7 <0.001
   WHR, % 73.5±5.0 74.0±6.6 0.6±7.5 0.111
   WHtR, % 42.9±4.1 43.5±5.1 0.5±4.6 0.017
   Systolic blood pressure, mm Hg 104.1±10.1 111.2±9.6 7.1±10.6 <0.001
   Diastolic blood pressure, mm Hg 60.4±7.2 65.5±8.0 5.1±8.3 <0.001
   Total cholesterol, mg/dL 162.1±26.6 164.9±25.6 3.7±20.6 <0.001
   Triglycerides, mg/dL 75 (56–65) 66 (52–84) −4.8±36.4 0.009
   HDL-C, mg/dL 50.2±11.0 56.9±11.4 7.3±9.6 <0.001
   Fasting glucose, mg/dL 86.4±6.8 81.8±7.4 −4.7±7.2 <0.001
   Insulin, µIU/L   8.6±2.8 9.9±4.6 1.3±4.6 <0.001
   HOMA-IR 1.8±0.7 2.0±1.2 0.2±1.1 0.002
Values are presented as mean±standard deviation or median (interquartile range).
BMI, body mass index; WC, waist circumference; WHR, waist-hip ratio; WHtR, waist-height ratio; HDL-C, high density lipoprotein cholester-
ol; HOMA-IR, homeostasis model assessment of insulin resistance. 
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tile to <95th percentile), or obese (≥95th percentile). Based on 
WC-for-age percentiles, participants were classified as normal 
(<90th percentile) or obese (≥90th percentile). The changes in 
anthropometric indices and fasting insulin levels were com-
puted as the difference between baseline and follow-up values. 
All statistical analyses were performed using SAS version 9.2 
(SAS Institute, Cary, NC, USA). Statistical significance was de-
fined as a two-sided P value less than 0.05.
RESULTS
The clinical and biochemical characteristics at baseline and 
their changes over 2.4 years are presented in Table 1. As would 
be expected, anthropometric indices, blood pressure, total 
cholesterol, HDL-C, and fasting insulin levels were increased 
in both sexes. Meanwhile, triglycerides and fasting glucose sig-
nificantly decreased in both sexes. Although BMI significantly 
increased in both sexes, BMI z-score decreased by 0.06 in 
males and by 0.19 in females on average. Fasting glucose de-
creased by 5.1 mg/dL in males and by 4.7 mg/dL in females on 
average. At follow-up, the proportion of hypertension, hyper-
glycemia, hypertriglyceridemia, and low HDL-C concentra-
tions was observed in 2.8%, 1.5%, 3.9%, and 17.2% of males, 
respectively. In females, the proportion of hypertension, hy-
perglycemia, hypertriglyceridemia, and low HDL-C concen-
trations was observed in 0.7%, 0.7%, 3.5%, and 33.6%, respec-
tively.
Results of multivariate linear regression analyses are pre-
sented in Table 2. In both sexes, increases in anthropometric 
indices were associated with increase in fasting insulin on fol-
low-up in the unadjusted model. These associations remained 
significant even after adjusting for baseline age, BMI (or WC), 
smoking, physical activity, and alcohol intake. In males, the 
change in BMI was more strongly associated with change in 
fasting insulin (BMI: β=1.026, P<0.001) than indices of ab-
dominal obesity (WC: β=0.822, P=0.001; WHR: β=0.586, P= 
0.012; WHtR: β=0.735, P=0.002). Meanwhile, in females, the 
change in indices of abdominal obesity was more strongly as-
sociated with change in fasting insulin (WC: β=1.258, P< 
0.001; WHR: β=1.183, P<0.001; WHtR: β=1.234, P<0.001) 
than BMI (β=1.047, P<0.001).
Results of subgroup analysis of obesity status at baseline are 
presented in Table 3. In analyses stratified by baseline BMI cat-
egories, the association between change in BMI and change in 
fasting insulin was stronger in the overweight group (males: 
β=1.136, P=0.028; females: β=1.262, P=0.389) and in the 
obese group (males: β=1.817, P=0.036; females: β=2.290, P= 
0.040), than in the normal group (males: β=0.957, P=0.008; 
females: β=0.976, P<0.001) at baseline after adjusting for 
baseline age, WC, smoking, physical activity, and alcohol in-
take. Similarly, in analyses stratified by baseline WC categories, 
the association between change in WC and change in fasting 
insulin was stronger in the obese group (males: β=1.806, P= 
0.060; females: β=2.080, P=0.017) than in the normal group 
(males: β=0.648, P=0.010; females: β=1.085, P<0.001) at 
baseline. There was a similar association between changes in 
obesity indices and change in HOMA-IR.
DISCUSSION
In this study, we demonstrated that the level of insulin increase 
was associated with changes in BMI, WC, WHR, and WHtR. 
Among the obesity indices, BMI and WC were more strongly 
associated with increase of fasting insulin levels than WHR 
and WHtR, and these associations were more pronounced 
among those who were overweight or obese at baseline com-
pared to normal weight participants.
Table 2. Association between changes in obesity indices and 
change in fasting insulin
Obesity indices 
Association with Δinsulin (µIU/L)
Unadjusted Adjusted
β P value β P value
Male (n=458)
   ΔBMI 0.905 <0.001 1.026 <0.001
   ΔWC 0.760 0.001 0.822 0.001
   ΔWHR 0.541 <0.001 0.586 0.012
   ΔWHtR 0.671 0.003 0.735 0.002
Female (n=426)
   ΔBMI 1.004 <0.001 1.047 <0.001
   ΔWC 1.020 <0.001 1.258 <0.001
   ΔWHR 0.982 <0.001 1.183 <0.001
   ΔWHtR 0.993 <0.001 1.234 <0.001
Adjusted for age, waist circumference (only BMI analysis), BMI (WC, 
WHR, and WHtR analysis), smoking status, alcohol intake, and phys-
ical activity at baseline.
Δ, change between baseline and follow-up; β, regression coefficients 
are calculated per one standard deviation for each anthropometric 
variable; BMI, body mass index; WC, waist circumference; WHR, 
waist-hip ratio; WHtR, waist-height ratio.
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Our findings are consistent with other studies showing that 
obesity is associated with fasting insulin levels, and both BMI 
and WC were strongly associated with serum insulin levels 
compared to other anthropometric indices [14-16]. In this 
study, fasting insulin levels are strongly associated with BMI in 
males, while they are associated with indicators of central obe-
sity (WC, WHR, and WHtR) in females, presumably because 
of the difference in growth rate between males and females. 
Before women start menstruating, they have already reached 
close to their maximum height [17]. On the other hand, the 
growth rate of men peaks when they are approximately 14 
years old, and the growth continues until about 18 to 20 years 
old [18]. Similarly, the average age of the participants in our 
study was 16 years old, which was when the growth spurts of 
the females was over, but the males continue to grow.
A cohort study of 3,313 children and adolescents aged 5 to 
17 years reported that elevated fasting insulin levels have been 
shown to persist over time in children [19]. In addition, anoth-
er previous study showed that participants aged 12 to 23 years 
with persistently high levels of insulin over the 8-year period 
had adverse effects on the levels of BMI, blood pressure, total 
cholesterol, triglycerides, and lipoprotein cholesterols, and 
they were more likely to develop hypertension, dyslipidemia, 
and obesity in young adulthood [20]. In our study, increasing 
levels of obesity indicators in obese adolescents at baseline was 
more closely associated with increasing fasting insulin levels 
than in those with normal weight. Our results indicated that 
obesity may play an important role in the association of the in-
creases of insulin levels. Chronic elevated blood insulin levels 
promote further insulin resistance through desensitization of 
target cells by reducing the number of receptors expressed at 
the cell surface [21,22]. Based on these mechanisms, the in-
crease in insulin levels during adolescence might be associated 
with the risk of early adulthood onset type 2 diabetes mellitus 
[23]. In addition, we also demonstrated that correlation be-
tween obesity and fasting blood glucose was weaker than insu-
lin levels in adolescents (Supplementary Table 1). According to 
previous studies [24,25], in adolescents, insulin resistance may 
Table 3. Association between changes in obesity indices and change in fasting insulin and HOMA-IR, stratified by obesity status 
at baseline
Obesity status at baseline No. of people
ΔInsulin ΔHOMA-IR
β P value β P value
Male (n=458)
   ΔBMI 
      Baseline BMI <85th percentile 381 0.957 0.008 0.136 0.078
      Baseline BMI 85th to <95th percentile 51 1.136 0.028 0.241 0.028
      Baseline BMI ≥95th percentile 26 1.817 0.036 0.408 0.037
   ΔWC
      Baseline WC <90th percentile 435 0.648 0.010 0.150 0.027
      Baseline WC ≥90th percentile 23 1.806 0.060 0.355 0.071
Female (n=426)
   ΔBMI 
      Baseline BMI <85th percentile 362 1.007 <0.001 0.216 0.001
      Baseline BMI 85th to <95th percentile 40 1.262 0.389 0.214 0.509
      Baseline BMI ≥95th percentile 24 2.535 0.016 0.557 0.011
   ΔWC
      Baseline WC <90th percentile   392 1.085 <0.001 0.220 0.002
      Baseline WC ≥90th percentile 34 2.080 0.017 0.479 0.013
Adjusted for age, waist circumference (only BMI analysis), BMI (only WC analysis), smoking status, alcohol intake, and physical activity at base-
line.
HOMA-IR, homeostasis model assessment of insulin resistance; Δ, change between baseline and follow-up; β, regression coefficients are calcu-
lated per one standard deviation for each anthropometric variable; BMI, body mass index; WC, waist circumference.
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be associated with normal fasting blood glucose due to pancre-
atic compensatory hyperinsulinemia. In young people without 
diabetes, although plasma glucose levels are maintained within 
a narrow range through puberty, have increased fasting insulin 
levels [26,27]. In fact, according to our results, the blood glu-
cose concentration decreased and the insulin concentration 
increased for 2 years. This may be a sign of insulin resistance, 
where insulin secretion increases with increasing adiposity to 
maintain normal glucose levels [28]. Adolescence is generally 
easy to think that healthy group with a low incidence rate of 
cardiovascular disease or mortality rate. However, even if the 
symptoms do not appear, most illnesses and many health 
problems already begin in adolescence. In the same vein, it can 
be overlooked that obese adolescents continue to have elevated 
levels of insulin to control their blood glucose. 
This study has some limitations. First, most of the study par-
ticipants were in the midst of puberty; thus, hormonal status 
may influence the indices of anthropometry, as well as glucose 
homeostasis variables. Moreover, insulin resistance during pu-
berty cannot be distinguished from insulin resistance due to 
obesity. In addition, our results showed that insulin concentra-
tion and HOMA-IR increased, but triglyceride, a factor associ-
ated with insulin resistance, decreased. Although we measured 
fasting insulin and calculated HOMA-IR, these indicators may 
not reflect changes in insulin resistance in adolescence. Sec-
ond, because of the lack of dietary intake data, this study did 
not address the role of diet in the regulation of glucose homeo-
stasis and related risk of obesity. Finally, this study was con-
ducted at a single high school and included one ethnic group; 
thus, the study findings cannot be generalized to other adoles-
cent populations. In cross-sectional study of general Korean 
adolescents [29], insulin and HOMA-IR decreased by increas-
ing age. When the same population was followed up as in our 
study, the results showed that insulin and HOMA-IR may in-
crease by increasing age. Therefore, more follow-up studies are 
needed for adolescents.
In conclusion, this study suggests that increase in BMI, WC, 
WHR, and WHtR were positively associated with increase in 
fasting insulin levels. Among all anthropometric indices, BMI 
and WC were more associated with elevated fasting insulin 
levels. Furthermore, compared with healthy adolescents, over-
weight or obese adolescents at baseline may have higher insu-
lin levels when anthropometric indices are increased. Al-
though insulin measurements are not recommended in ado-
lescents [30], our results suggest that changes in obesity indices 
in adolescence may lead to an increase in insulin concentra-
tions and HOMA-IR. As in many areas of child health, in-
creases in anthropometric indices during adolescence will af-
fect the overall health during adulthood. Therefore, lifestyle 
practices that prevent or control obesity are important during 
adolescence, and these practices may help prevent hyperglyce-
mia, insulin resistance, and even diabetes.
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